GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 827 filers reported holding GLAXOSMITHKLINE PLC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,436,000 | +30.3% | 32,987 | +30.3% | 0.07% | +26.4% |
Q1 2022 | $1,102,000 | +35.4% | 25,315 | +37.2% | 0.05% | +10.4% |
Q4 2021 | $814,000 | +68.5% | 18,449 | +46.0% | 0.05% | +11.6% |
Q3 2021 | $483,000 | +7.8% | 12,639 | +12.4% | 0.04% | -8.5% |
Q2 2021 | $448,000 | +25.1% | 11,240 | +12.1% | 0.05% | -13.0% |
Q1 2021 | $358,000 | +5.0% | 10,030 | +8.4% | 0.05% | -27.0% |
Q4 2020 | $341,000 | -23.2% | 9,256 | -21.5% | 0.07% | -40.8% |
Q3 2020 | $444,000 | +1.4% | 11,785 | +9.8% | 0.12% | -37.2% |
Q2 2020 | $438,000 | – | 10,731 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |